CILGAVIMAB\TIXAGEVIMAB for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where CILGAVIMAB\TIXAGEVIMAB was used for Multiple sclerosis.
Most Reported Side Effects for CILGAVIMAB\TIXAGEVIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Covid-19 | 521 | 24.0% | 103 | 365 |
| Drug ineffective | 123 | 5.7% | 16 | 75 |
| Product use issue | 94 | 4.3% | 26 | 42 |
| Fatigue | 86 | 4.0% | 2 | 16 |
| Headache | 86 | 4.0% | 4 | 16 |
| Dyspnoea | 84 | 3.9% | 9 | 36 |
| Pyrexia | 81 | 3.7% | 4 | 48 |
| Nausea | 68 | 3.1% | 0 | 17 |
| Dizziness | 64 | 3.0% | 1 | 18 |
| Breakthrough covid-19 | 51 | 2.4% | 6 | 34 |
| Pneumonia | 49 | 2.3% | 8 | 34 |
| Atrial fibrillation | 48 | 2.2% | 3 | 31 |
| Death | 48 | 2.2% | 48 | 3 |
| Cough | 47 | 2.2% | 2 | 13 |
| Pruritus | 46 | 2.1% | 0 | 6 |
Other Indications for CILGAVIMAB\TIXAGEVIMAB
Covid-19 prophylaxis (1,105)
Covid-19 (287)
Covid-19 treatment (146)
Immunodeficiency (76)
Prophylaxis (57)
Product used for unknown indication (30)
Immunisation (23)
Immunosuppression (15)
Renal transplant (14)
Covid-19 immunisation (12)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)